SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-321550
Filing Date
2013-08-06
Accepted
2013-08-06 16:11:19
Documents
12
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d557868d10q.htm 10-Q 453646
2 EX-10.1 d557868dex101.htm EX-10.1 23957
3 EX-31.1 d557868dex311.htm EX-31.1 6987
4 EX-31.2 d557868dex312.htm EX-31.2 6843
5 EX-32.1 d557868dex321.htm EX-32.1 4395
6 EX-32.2 d557868dex322.htm EX-32.2 4341
  Complete submission text file 0001193125-13-321550.txt   3450363

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT acad-20130630.xml EX-101.INS 293263
8 XBRL TAXONOMY EXTENSION SCHEMA acad-20130630.xsd EX-101.SCH 25872
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acad-20130630_cal.xml EX-101.CAL 39931
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acad-20130630_def.xml EX-101.DEF 58115
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20130630_lab.xml EX-101.LAB 180893
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20130630_pre.xml EX-101.PRE 126015
Mailing Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SAN DIEGO CA 92121 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50768 | Film No.: 131013630
SIC: 2834 Pharmaceutical Preparations